Last reviewed · How we verify

A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors

NCT03815084 EARLY_PHASE1 UNKNOWN

clinical study on the safety and efficacy of PD1 combined with dc-Nk in the treatment of solid tumors

Details

Lead sponsorAllife Medical Science and Technology Co., Ltd.
PhaseEARLY_PHASE1
StatusUNKNOWN
Enrolment100
Start dateFri Feb 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionMon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions